More on LGVN
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $0.73 |
|
|||
| Open | $0.72 | ||||
| 52 Wk High | $1.62 | ||||
| 52 Wk Low | $0.35 | ||||
| Day High | $0.75 | ||||
| Day Low | $0.68 | ||||
| P/E | N/A | ||||
| EPS | $-0.17 | ||||
| Volume | 267,513 | ||||
- Longeveron stem cell therapy data to be presented at 2026 AAIC
- New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer’s Disease Accepted for Poster Presentation at the 2026 Alzheimer’s Association International Conference (AA
- Longeveron receives SME status from European Medicines Agency
- Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA)
- Longeveron CFO Lisa Locklear to step down in July
- Form 8-K Longeveron Inc. For: Jun 01
- Longeveron to Present at BIO International Convention 2026
- Form ARS Longeveron Inc. For: Dec 31
- Form DEFA14A Longeveron Inc.
- Form DEF 14A Longeveron Inc. For: Jul 01
Entities mentioned with LGVN
- FDA | View Related Stories »
- Earnings | View Related Stories »
- S1 | View Related Stories »
- H.C. Wainwright | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- IPO | View Related Stories »
- Show More...
